Diacerein
Diacerein is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| OTC monograph final | 2013-01-07 | |
| 12-pack hand sanitizer dark 6-pack hand sanitizer light 6-pack hand sanitizer | C200263 | 2025-08-17 |
| 2-oak mix, red/white pollen 3-oak mix, black/blackjack/post pollen 3-ragweed mix, giant/short/western pollen 4-pine mix, austrian/loblolly/scotch/w... | Biologic Licensing Application | 2011-03-11 |
| 4 in 1 pressed mineral spf 15 golden dark | OTC monograph not final | 2011-09-15 |
| 4 in 1 pressed mineral spf 15 medium dark | OTC monograph not final | 2011-09-15 |
| abella | OTC monograph final | 2020-01-17 |
| ailanthus allscale burrobrush burweed marsh elder carelessweed cocklebur common sagebrush curly dock dandelion darkleaves mugwort dog fennel englis... | Biologic Licensing Application | 2009-12-04 |
| almay clear complexion pressed powder | C200263 | 2024-12-30 |
| aloe up | OTC monograph final | 2020-01-17 |
| aloe up dark tanning oil spf 4 | C200263 | 2024-02-13 |
Show 200 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
103 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | 3 | 5 | 1 | 9 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | 2 | 5 | — | 7 |
| Neoplasms | D009369 | — | C80 | 3 | 1 | — | 1 | 1 | 5 |
| Pain | D010146 | EFO_0003843 | R52 | — | — | — | 1 | — | 1 |
| Meibomian gland dysfunction | D000080343 | — | H02.88 | — | — | — | 1 | — | 1 |
| Inflammation | D007249 | MP_0001845 | — | — | — | — | 1 | — | 1 |
| Febrile neutropenia | D064147 | — | — | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 5 | 2 | — | 3 | 10 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | 5 | 2 | — | 2 | 9 |
| Epidermolysis bullosa | D004820 | — | Q81 | 1 | 4 | 1 | — | — | 5 |
| Epidermolysis bullosa simplex | D016110 | — | Q81.0 | 1 | 3 | 1 | — | — | 4 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | 1 | — | — | 1 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | — | 1 | — | — | 1 |
| Fatty liver | D005234 | EFO_0003934 | — | — | — | 1 | — | — | 1 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | 1 | — | — | 1 |
| Melanoma | D008545 | — | — | — | 1 | 1 | — | — | 1 |
| Uveal neoplasms | D014604 | EFO_1001230 | — | — | 1 | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | — | 3 | — | — | 1 | 4 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | 2 | 3 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 2 | 3 |
| Non-small-cell lung carcinoma | D002289 | — | — | 2 | 2 | — | — | — | 3 |
| Colorectal neoplasms | D015179 | — | — | — | 1 | — | — | 2 | 3 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | — | 2 | — | — | — | 2 |
| Diabetes complications | D048909 | — | — | — | 2 | — | — | — | 2 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 1 | — | — | 1 | 2 |
| Overweight | D050177 | — | E66.3 | — | 1 | — | — | 1 | 2 |
| Psoriasis | D011565 | EFO_0000676 | L40 | — | 1 | — | — | 1 | 2 |
Show 24 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
| Multiple myeloma | D009101 | — | C90.0 | 2 | — | — | — | — | 2 |
| Plasma cell neoplasms | D054219 | — | — | 2 | — | — | — | — | 2 |
| Darier disease | D007644 | Orphanet_218 | E50.8 | 1 | — | — | — | 1 | 2 |
| Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
| Botulism | D001906 | EFO_0005542 | A05.1 | 1 | — | — | — | — | 1 |
| Benign familial pemphigus | D016506 | — | Q82.8 | 1 | — | — | — | — | 1 |
| Epidermolysis bullosa dystrophica | D016108 | — | Q81.2 | 1 | — | — | — | — | 1 |
| Junctional epidermolysis bullosa | D016109 | — | Q81.1 | 1 | — | — | — | — | 1 |
| Fasting | D005215 | EFO_0002756 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hiv | D006678 | — | O98.7 | — | — | — | — | 3 | 3 |
| Edentulous mouth | D009066 | — | — | — | — | — | — | 2 | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
| Fever | D005334 | — | R50.9 | — | — | — | — | 2 | 2 |
| Hyperthermia | D000084462 | — | — | — | — | — | — | 2 | 2 |
| Mental disorders | D001523 | EFO_0000677 | F91.9 | — | — | — | — | 2 | 2 |
| Child development | D002657 | — | — | — | — | — | — | 2 | 2 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | — | — | — | 1 | 1 |
| Highly active antiretroviral therapy | D023241 | — | — | — | — | — | — | 1 | 1 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
Show 39 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Diacerein |
| INN | diacerein |
| Description | 4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)Oc1cccc2c1C(=O)c1c(OC(C)=O)cc(C(=O)O)cc1C2=O |
Identifiers
| PDB | — |
| CAS-ID | 13739-02-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL41286 |
| ChEBI ID | — |
| PubChem CID | 26248 |
| DrugBank | DB11994 |
| UNII ID | 4HU6J11EL5 (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Aranesp – Amgen
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Darzalex – Johnson & Johnson
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 65,794 documents
View more details
Safety
Black-box Warning
Black-box warning for: 2-oak mix, red/white pollen 3-oak mix, black/blackjack/post pollen 3-ragweed mix, giant/short/western pollen 4-pine mix, austrian/loblolly/scotch/w..., Ailanthus allscale burrobrush burweed marsh elder carelessweed cocklebur common sagebrush curly dock dandelion darkleaves mugwort dog fennel englis..., Aranesp, Darunavir, Darvon-n, Symtuza, Urban decay naked skin dark beauty balm spf20
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
196,699 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use